Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Brazil Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20112
20121
20131
20151
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company3
Bristol-Myers Squibb2
Viatris Innovation GmbH2
Anthera Pharmaceuticals1
Baxalta now part of Shire1
Eli Lilly and Company1
GlaxoSmithKline1
Human Genome Sciences Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases13
Lupus Erythematosus, Systemic10
Connective Tissue Diseases6
Immune System Diseases6
Arthritis, Rheumatoid1
Autoimmune Diseases of the Nervous System1
Demyelinating Diseases1
Glomerulonephritis1
Joint Diseases1
Kidney Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.